These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22411707)

  • 21. Investigation of the physical stability of amorphous drug and drug/polymer melts using variable temperature solid state NMR.
    Forster A; Apperley D; Hempenstall J; Lancaster R; Rades T
    Pharmazie; 2003 Oct; 58(10):761-2. PubMed ID: 14609294
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of polymer content on stabilizing milled amorphous salbutamol sulphate.
    Balani PN; Wong SY; Ng WK; Widjaja E; Tan RB; Chan SY
    Int J Pharm; 2010 May; 391(1-2):125-36. PubMed ID: 20211717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
    Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
    J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anomalous properties of spray dried solid dispersions.
    Al-Obaidi H; Brocchini S; Buckton G
    J Pharm Sci; 2009 Dec; 98(12):4724-37. PubMed ID: 19455622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solubilization and interaction of sulindac with polyvinylpyrrolidone K30 in the solid state and in aqueous solution.
    Tros de Ilarduya MC; Martín C; Goñi MM; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 1998 Mar; 24(3):295-300. PubMed ID: 9876588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
    Priemel PA; Laitinen R; Grohganz H; Rades T; Strachan CJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.
    Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
    Int J Pharm; 2007 May; 336(1):22-34. PubMed ID: 17174493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation of L-Ascorbic Acid in the Amorphous Solid State.
    Sanchez JO; Ismail Y; Christina B; Mauer LJ
    J Food Sci; 2018 Mar; 83(3):670-681. PubMed ID: 29405290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amorphous formulations of indomethacin and griseofulvin prepared by electrospinning.
    Lopez FL; Shearman GC; Gaisford S; Williams GR
    Mol Pharm; 2014 Dec; 11(12):4327-38. PubMed ID: 25317777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding API-polymer proximities in amorphous stabilized composite drug products using fluorine-carbon 2D HETCOR solid-state NMR.
    Abraham A; Crull G
    Mol Pharm; 2014 Oct; 11(10):3754-9. PubMed ID: 25152063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detailed stability investigation of amorphous solid dispersions prepared by single-needle and high speed electrospinning.
    Démuth B; Farkas A; Pataki H; Balogh A; Szabó B; Borbás E; Sóti PL; Vigh T; Kiserdei É; Farkas B; Mensch J; Verreck G; Van Assche I; Marosi G; Nagy ZK
    Int J Pharm; 2016 Feb; 498(1-2):234-44. PubMed ID: 26705153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isothermal microcalorimetry to investigate the phase separation for amorphous solid dispersions of AMG 517 with HPMC-AS.
    Calahan JL; Zanon RL; Alvarez-Nunez F; Munson EJ
    Mol Pharm; 2013 May; 10(5):1949-57. PubMed ID: 23574401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrospun nanofibers as a potential controlled-release solid dispersion system for poorly water-soluble drugs.
    Paaver U; Heinämäki J; Laidmäe I; Lust A; Kozlova J; Sillaste E; Kirsimäe K; Veski P; Kogermann K
    Int J Pharm; 2015 Feb; 479(1):252-60. PubMed ID: 25549852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
    Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solid state NMR perspective of drug-polymer solid solutions: a model system based on poly(ethylene oxide).
    Schachter DM; Xiong J; Tirol GC
    Int J Pharm; 2004 Aug; 281(1-2):89-101. PubMed ID: 15288346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An investigation into the dissolution properties of celecoxib melt extrudates: understanding the role of polymer type and concentration in stabilizing supersaturated drug concentrations.
    Abu-Diak OA; Jones DS; Andrews GP
    Mol Pharm; 2011 Aug; 8(4):1362-71. PubMed ID: 21696180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion.
    Puri V; Dantuluri AK; Bansal AK
    J Pharm Sci; 2011 Jun; 100(6):2460-8. PubMed ID: 21246560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.